HI
Humankind Investments Portfolio holdings
AUM
$410M
This Quarter Return
-0.1%
1 Year Return
+11.36%
3 Year Return
+48.94%
5 Year Return
–
10 Year Return
–
AUM
$65.6M
AUM Growth
+$65.6M
(+17%)
Cap. Flow
+$881K
Cap. Flow
% of AUM
1.34%
Top 10 Holdings %
Top 10 Hldgs %
34.73%
Holding
104
New
23
Increased
50
Reduced
26
Closed
5
Top Buys
| 1 |
Bunge Global
BG
|
$1.15M |
| 2 |
Corteva
CTVA
|
$944K |
| 3 |
Verizon
VZ
|
$801K |
| 4 |
Sysco
SYY
|
$542K |
| 5 |
Archer Daniels Midland
ADM
|
$460K |
Top Sells
| 1 |
GE Aerospace
GE
|
$8.14M |
| 2 |
HP
HPQ
|
$769K |
| 3 |
Deere & Co
DE
|
$752K |
| 4 |
Charter Communications
CHTR
|
$624K |
| 5 |
Dell
DELL
|
$521K |
Sector Composition
| 1 | Healthcare | 36.07% |
| 2 | Consumer Staples | 17.83% |
| 3 | Communication Services | 14.99% |
| 4 | Materials | 9.97% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class A
GOOGL
$2.53T
| $3.82M | 5.81% |
1,427
-133
| -9% | -$356K |
|
|
2
Verizon
VZ
$187B
| $3.81M | 5.8% |
70,467
+14,822
| +27% | +$801K |
|
|
3
Corteva
CTVA
$50.2B
| $3.21M | 4.9% |
76,365
+22,439
| +42% | +$944K |
|
|
4
Bunge Global
BG
$16.7B
| $2.17M | 3.31% |
26,687
+14,111
| +112% | +$1.15M |
|
|
5
GE Aerospace
GE
$289B
| $1.8M | 2.74% |
17,471
-78,985
| -82% | -$8.14M |
|
6
Johnson & Johnson
JNJ
$429B
| $1.75M | 2.67% |
10,848
+743
| +7% | +$120K |
|
7
Procter & Gamble
PG
$371B
| $1.65M | 2.52% |
11,809
+2,929
| +33% | +$409K |
|
8
HCA Healthcare
HCA
$95.1B
| $1.59M | 2.42% |
6,545
+224
| +4% | +$54.4K |
|
9
Pfizer
PFE
$142B
| $1.55M | 2.36% |
36,003
-6,334
| -15% | -$272K |
|
10
American Water Works
AWK
$28B
| $1.45M | 2.21% |
8,572
+1,282
| +18% | +$217K |
|
|
11
Deere & Co
DE
$130B
| $1.31M | 1.99% |
3,895
-2,244
| -37% | -$752K |
|
12
AbbVie
ABBV
$372B
| $1.23M | 1.87% |
11,389
+2,282
| +25% | +$246K |
|
13
PepsiCo
PEP
$210B
| $1.23M | 1.87% |
8,164
+2,176
| +36% | +$327K |
|
14
Merck
MRK
$213B
| $1.13M | 1.73% |
15,097
-539
| -3% | -$40.5K |
|
15
Bristol-Myers Squibb
BMY
$96.9B
| $1.11M | 1.68% |
18,672
+1,441
| +8% | +$85.3K |
|
16
Xylem
XYL
$34B
| $1.02M | 1.55% |
8,222
+2,319
| +39% | +$287K |
|
17
McKesson
MCK
$85.8B
| $930K | 1.42% |
4,663
+1,111
| +31% | +$222K |
|
18
Ecolab
ECL
$78.2B
| $913K | 1.39% |
4,375
+1,154
| +36% | +$241K |
|
19
Eli Lilly
LLY
$654B
| $893K | 1.36% |
3,867
-148
| -4% | -$34.2K |
|
20
CF Industries
CF
$14.1B
| $878K | 1.34% |
15,727
+4,602
| +41% | +$257K |
|
21
Amgen
AMGN
$155B
| $875K | 1.33% |
4,113
+1,177
| +40% | +$250K |
|
22
FMC
FMC
$4.82B
| $838K | 1.28% |
9,152
+4,143
| +83% | +$379K |
|
23
IQVIA
IQV
$31.7B
| $831K | 1.27% |
3,471
+132
| +4% | +$31.6K |
|
24
Labcorp
LH
$23.1B
| $816K | 1.24% |
2,901
+132
| +5% | +$37.1K |
|
25
JPMorgan Chase
JPM
$819B
| $794K | 1.21% |
4,848
+2,319
| +92% | +$380K |
|